close read more

Servier joins the Act4Nature International Initiative


Servier joins the Act4Nature International Initiative

The Group has strengthened its commitment to biodiversity by integrating it into the corporate social responsibility strategy.

Servier has joined Act4Nature International, a voluntary commitment initiative in favor of biodiversity. By taking this step, Servier undertakes to comply with the 10 joint commitments outlined by Act4Nature as well as individual commitments incorporated into the CSR strategy.


SMART commitments

The Group’s commitments are focused on four areas:

  • Evaluating and reducing the impact of products on biodiversity
  • Reducing sites’ impact on biodiversity
  • Raising awareness and developing skills on biodiversity issues
  • Participating in biodiversity protection projects


These four priority areas stem from an impact study carried out within the Group in 2021.

The Act4Nature steering committee, made up of environmental NGOs, business networks, and scientific partners, has approved the SMART criteria (Specific, Measurable, Attainable, Relevant, Time-bound) of Servier’s commitments, thereby ensuring rollout within the Group.


“By joining Act4Nature, we reaffirm Servier Group’s commitment to biodiversity with specific actions that respond to the challenges facing the planet,” declared Vincent Minvielle, Group CSR Director. Among the actions initiated: reducing the environmental impact of our industrial chemical synthesis, through the deployment of ‘Green Score’, an internal evaluation tool, and obtaining in the future the BiodiverCity® label for the Servier Research and Development Institute, which will open its doors in 2023 in Paris-Saclay.”


Read Act4Nature’s joint commitments

Read Servier’s individual commitments

Find out more about Servier’s climate commitments

Read the press release


Last news

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Patient associations’ perception of pharmaceutical companies: Servier is making progress!